• レポートコード:GIR-105X13145 • 出版社/出版日: / 2021年5月 • レポート形態:英文、PDF、138ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:Pharma & Healthcare |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、オクスカルバゼピン錠のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オクスカルバゼピン錠の種類別市場規模(錠剤(150mg)、錠剤(300mg)、錠剤(600mg))、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オクスカルバゼピン錠の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Novartis (Trileptal)、Supernus Pharmaceuticals (Oxtellar XR)、Apotex、Sun Pharm、Jubilant Generics、Taro Pharmaceuticals、Stada Group、Mylan、Teva Pharmaceutical、Hikma Pharmaceuticals、ANI Pharmaceuticals、Glenmark Pharmaceuticals、Roxane Laboratories、Nobelpharma、Jamp Pharma、Neuraxpharm、Orion Corporation、SihuanPharm、Humanwell Healthcare、Huikang Pharmaceutical、Nexgen pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:錠剤(150mg)、錠剤(300mg)、錠剤(600mg) ・用途別分析2016年-2026年:病院薬局、小売薬局、オンライン薬局 ・オクスカルバゼピン錠の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・オクスカルバゼピン錠のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・オクスカルバゼピン錠のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・オクスカルバゼピン錠の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・オクスカルバゼピン錠の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oxcarbazepine Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oxcarbazepine Tablets size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oxcarbazepine Tablets market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oxcarbazepine Tablets market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets (150mg)
Tablets (300mg)
Tablets (600mg)
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
The key market players for global Oxcarbazepine Tablets market are listed below:
Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Apotex
Sun Pharm
Jubilant Generics
Taro Pharmaceuticals
Stada Group
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
ANI Pharmaceuticals
Glenmark Pharmaceuticals
Roxane Laboratories
Nobelpharma
Jamp Pharma
Neuraxpharm
Orion Corporation
SihuanPharm
Humanwell Healthcare
Huikang Pharmaceutical
Nexgen pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oxcarbazepine Tablets Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oxcarbazepine Tablets Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablets (150mg)
1.2.3 Tablets (300mg)
1.2.4 Tablets (600mg)
1.3 Market Analysis by Application
1.3.1 Overview: Global Oxcarbazepine Tablets Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Oxcarbazepine Tablets Market Size & Forecast
1.4.1 Global Oxcarbazepine Tablets Sales in Value (2016-2026))
1.4.2 Global Oxcarbazepine Tablets Sales in Volume (2016-2026)
1.4.3 Global Oxcarbazepine Tablets Price by Type (2016-2026) & (USD/Unit)
1.5 Global Oxcarbazepine Tablets Production Capacity Analysis
1.5.1 Global Oxcarbazepine Tablets Total Production Capacity (2016-2026)
1.5.2 Global Oxcarbazepine Tablets Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oxcarbazepine Tablets Market Drivers
1.6.2 Oxcarbazepine Tablets Market Restraints
1.6.3 Oxcarbazepine Tablets Trends Analysis
2 Manufacturers Profiles
2.1 Novartis (Trileptal)
2.1.1 Novartis (Trileptal) Details
2.1.2 Novartis (Trileptal) Major Business
2.1.3 Novartis (Trileptal) Oxcarbazepine Tablets Product and Services
2.1.4 Novartis (Trileptal) Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Supernus Pharmaceuticals (Oxtellar XR)
2.2.1 Supernus Pharmaceuticals (Oxtellar XR) Details
2.2.2 Supernus Pharmaceuticals (Oxtellar XR) Major Business
2.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Product and Services
2.2.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Apotex
2.3.1 Apotex Details
2.3.2 Apotex Major Business
2.3.3 Apotex Oxcarbazepine Tablets Product and Services
2.3.4 Apotex Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sun Pharm
2.4.1 Sun Pharm Details
2.4.2 Sun Pharm Major Business
2.4.3 Sun Pharm Oxcarbazepine Tablets Product and Services
2.4.4 Sun Pharm Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Jubilant Generics
2.5.1 Jubilant Generics Details
2.5.2 Jubilant Generics Major Business
2.5.3 Jubilant Generics Oxcarbazepine Tablets Product and Services
2.5.4 Jubilant Generics Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Taro Pharmaceuticals
2.6.1 Taro Pharmaceuticals Details
2.6.2 Taro Pharmaceuticals Major Business
2.6.3 Taro Pharmaceuticals Oxcarbazepine Tablets Product and Services
2.6.4 Taro Pharmaceuticals Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Stada Group
2.7.1 Stada Group Details
2.7.2 Stada Group Major Business
2.7.3 Stada Group Oxcarbazepine Tablets Product and Services
2.7.4 Stada Group Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Oxcarbazepine Tablets Product and Services
2.8.4 Mylan Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business
2.9.3 Teva Pharmaceutical Oxcarbazepine Tablets Product and Services
2.9.4 Teva Pharmaceutical Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Hikma Pharmaceuticals
2.10.1 Hikma Pharmaceuticals Details
2.10.2 Hikma Pharmaceuticals Major Business
2.10.3 Hikma Pharmaceuticals Oxcarbazepine Tablets Product and Services
2.10.4 Hikma Pharmaceuticals Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 ANI Pharmaceuticals
2.11.1 ANI Pharmaceuticals Details
2.11.2 ANI Pharmaceuticals Major Business
2.11.3 ANI Pharmaceuticals Oxcarbazepine Tablets Product and Services
2.11.4 ANI Pharmaceuticals Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Glenmark Pharmaceuticals
2.12.1 Glenmark Pharmaceuticals Details
2.12.2 Glenmark Pharmaceuticals Major Business
2.12.3 Glenmark Pharmaceuticals Oxcarbazepine Tablets Product and Services
2.12.4 Glenmark Pharmaceuticals Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Roxane Laboratories
2.13.1 Roxane Laboratories Details
2.13.2 Roxane Laboratories Major Business
2.13.3 Roxane Laboratories Oxcarbazepine Tablets Product and Services
2.13.4 Roxane Laboratories Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Nobelpharma
2.14.1 Nobelpharma Details
2.14.2 Nobelpharma Major Business
2.14.3 Nobelpharma Oxcarbazepine Tablets Product and Services
2.14.4 Nobelpharma Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Jamp Pharma
2.15.1 Jamp Pharma Details
2.15.2 Jamp Pharma Major Business
2.15.3 Jamp Pharma Oxcarbazepine Tablets Product and Services
2.15.4 Jamp Pharma Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Neuraxpharm
2.16.1 Neuraxpharm Details
2.16.2 Neuraxpharm Major Business
2.16.3 Neuraxpharm Oxcarbazepine Tablets Product and Services
2.16.4 Neuraxpharm Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Orion Corporation
2.17.1 Orion Corporation Details
2.17.2 Orion Corporation Major Business
2.17.3 Orion Corporation Oxcarbazepine Tablets Product and Services
2.17.4 Orion Corporation Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 SihuanPharm
2.18.1 SihuanPharm Details
2.18.2 SihuanPharm Major Business
2.18.3 SihuanPharm Oxcarbazepine Tablets Product and Services
2.18.4 SihuanPharm Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Humanwell Healthcare
2.19.1 Humanwell Healthcare Details
2.19.2 Humanwell Healthcare Major Business
2.19.3 Humanwell Healthcare Oxcarbazepine Tablets Product and Services
2.19.4 Humanwell Healthcare Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Huikang Pharmaceutical
2.20.1 Huikang Pharmaceutical Details
2.20.2 Huikang Pharmaceutical Major Business
2.20.3 Huikang Pharmaceutical Oxcarbazepine Tablets Product and Services
2.20.4 Huikang Pharmaceutical Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Nexgen pharma
2.21.1 Nexgen pharma Details
2.21.2 Nexgen pharma Major Business
2.21.3 Nexgen pharma Oxcarbazepine Tablets Product and Services
2.21.4 Nexgen pharma Oxcarbazepine Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oxcarbazepine Tablets Sales by Manufacturer
3.1 Global Oxcarbazepine Tablets Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oxcarbazepine Tablets Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oxcarbazepine Tablets
3.4 Market Concentration Rate
3.4.1 Top 3 Oxcarbazepine Tablets Manufacturer Market Share
3.4.2 Top 6 Oxcarbazepine Tablets Manufacturer Market Share
3.5 Global Oxcarbazepine Tablets Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oxcarbazepine Tablets Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oxcarbazepine Tablets Market Size by Region
4.1.1 Global Oxcarbazepine Tablets Sales in Volume by Region (2016-2026)
4.1.2 Global Oxcarbazepine Tablets Revenue by Region (2016-2026)
4.2 North America Oxcarbazepine Tablets Revenue (2016-2026)
4.3 Europe Oxcarbazepine Tablets Revenue (2016-2026)
4.4 Asia-Pacific Oxcarbazepine Tablets Revenue (2016-2026)
4.5 South America Oxcarbazepine Tablets Revenue (2016-2026)
4.6 Middle East and Africa Oxcarbazepine Tablets Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oxcarbazepine Tablets Sales in Volume by Type (2016-2026)
5.2 Global Oxcarbazepine Tablets Revenue by Type (2016-2026)
5.3 Global Oxcarbazepine Tablets Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oxcarbazepine Tablets Sales in Volume by Application (2016-2026)
6.2 Global Oxcarbazepine Tablets Revenue by Application (2016-2026)
6.3 Global Oxcarbazepine Tablets Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oxcarbazepine Tablets Sales by Type (2016-2026)
7.2 North America Oxcarbazepine Tablets Sales by Application (2016-2026)
7.3 North America Oxcarbazepine Tablets Market Size by Country
7.3.1 North America Oxcarbazepine Tablets Sales in Volume by Country (2016-2026)
7.3.2 North America Oxcarbazepine Tablets Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oxcarbazepine Tablets Sales by Type (2016-2026)
8.2 Europe Oxcarbazepine Tablets Sales by Application (2016-2026)
8.3 Europe Oxcarbazepine Tablets Market Size by Country
8.3.1 Europe Oxcarbazepine Tablets Sales in Volume by Country (2016-2026)
8.3.2 Europe Oxcarbazepine Tablets Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oxcarbazepine Tablets Sales by Type (2016-2026)
9.2 Asia-Pacific Oxcarbazepine Tablets Sales by Application (2016-2026)
9.3 Asia-Pacific Oxcarbazepine Tablets Market Size by Region
9.3.1 Asia-Pacific Oxcarbazepine Tablets Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oxcarbazepine Tablets Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oxcarbazepine Tablets Sales by Type (2016-2026)
10.2 South America Oxcarbazepine Tablets Sales by Application (2016-2026)
10.3 South America Oxcarbazepine Tablets Market Size by Country
10.3.1 South America Oxcarbazepine Tablets Sales in Volume by Country (2016-2026)
10.3.2 South America Oxcarbazepine Tablets Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oxcarbazepine Tablets Sales by Type (2016-2026)
11.2 Middle East & Africa Oxcarbazepine Tablets Sales by Application (2016-2026)
11.3 Middle East & Africa Oxcarbazepine Tablets Market Size by Country
11.3.1 Middle East & Africa Oxcarbazepine Tablets Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oxcarbazepine Tablets Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oxcarbazepine Tablets Typical Distributors
12.3 Oxcarbazepine Tablets Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oxcarbazepine Tablets Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oxcarbazepine Tablets Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis (Trileptal) Basic Information, Manufacturing Base and Competitors
Table 4. Novartis (Trileptal) Major Business
Table 5. Novartis (Trileptal) Oxcarbazepine Tablets Product and Services
Table 6. Novartis (Trileptal) Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Supernus Pharmaceuticals (Oxtellar XR) Basic Information, Manufacturing Base and Competitors
Table 8. Supernus Pharmaceuticals (Oxtellar XR) Major Business
Table 9. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Product and Services
Table 10. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Apotex Basic Information, Manufacturing Base and Competitors
Table 12. Apotex Major Business
Table 13. Apotex Oxcarbazepine Tablets Product and Services
Table 14. Apotex Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sun Pharm Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharm Major Business
Table 17. Sun Pharm Oxcarbazepine Tablets Product and Services
Table 18. Sun Pharm Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 20. Jubilant Generics Major Business
Table 21. Jubilant Generics Oxcarbazepine Tablets Product and Services
Table 22. Jubilant Generics Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Taro Pharmaceuticals Major Business
Table 25. Taro Pharmaceuticals Oxcarbazepine Tablets Product and Services
Table 26. Taro Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Stada Group Basic Information, Manufacturing Base and Competitors
Table 28. Stada Group Major Business
Table 29. Stada Group Oxcarbazepine Tablets Product and Services
Table 30. Stada Group Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Oxcarbazepine Tablets Product and Services
Table 34. Mylan Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Teva Pharmaceutical Major Business
Table 37. Teva Pharmaceutical Oxcarbazepine Tablets Product and Services
Table 38. Teva Pharmaceutical Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Hikma Pharmaceuticals Major Business
Table 41. Hikma Pharmaceuticals Oxcarbazepine Tablets Product and Services
Table 42. Hikma Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. ANI Pharmaceuticals Major Business
Table 45. ANI Pharmaceuticals Oxcarbazepine Tablets Product and Services
Table 46. ANI Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Glenmark Pharmaceuticals Major Business
Table 49. Glenmark Pharmaceuticals Oxcarbazepine Tablets Product and Services
Table 50. Glenmark Pharmaceuticals Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Roxane Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. Roxane Laboratories Major Business
Table 53. Roxane Laboratories Oxcarbazepine Tablets Product and Services
Table 54. Roxane Laboratories Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Nobelpharma Basic Information, Manufacturing Base and Competitors
Table 56. Nobelpharma Major Business
Table 57. Nobelpharma Oxcarbazepine Tablets Product and Services
Table 58. Nobelpharma Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Jamp Pharma Major Business
Table 61. Jamp Pharma Oxcarbazepine Tablets Product and Services
Table 62. Jamp Pharma Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Neuraxpharm Basic Information, Manufacturing Base and Competitors
Table 64. Neuraxpharm Major Business
Table 65. Neuraxpharm Oxcarbazepine Tablets Product and Services
Table 66. Neuraxpharm Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 68. Orion Corporation Major Business
Table 69. Orion Corporation Oxcarbazepine Tablets Product and Services
Table 70. Orion Corporation Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. SihuanPharm Basic Information, Manufacturing Base and Competitors
Table 72. SihuanPharm Major Business
Table 73. SihuanPharm Oxcarbazepine Tablets Product and Services
Table 74. SihuanPharm Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 76. Humanwell Healthcare Major Business
Table 77. Humanwell Healthcare Oxcarbazepine Tablets Product and Services
Table 78. Humanwell Healthcare Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Huikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Huikang Pharmaceutical Major Business
Table 81. Huikang Pharmaceutical Oxcarbazepine Tablets Product and Services
Table 82. Huikang Pharmaceutical Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Nexgen pharma Basic Information, Manufacturing Base and Competitors
Table 84. Nexgen pharma Major Business
Table 85. Nexgen pharma Oxcarbazepine Tablets Product and Services
Table 86. Nexgen pharma Oxcarbazepine Tablets Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Global Oxcarbazepine Tablets Sales by Manufacturer (2019-2021e) & (M Unit)
Table 88. Global Oxcarbazepine Tablets Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 89. Market Position of Manufacturers in Oxcarbazepine Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 90. Global Oxcarbazepine Tablets Production Capacity by Company, (M Unit): 2020 VS 2021
Table 91. Head Office and Oxcarbazepine Tablets Production Site of Key Manufacturer
Table 92. Global Oxcarbazepine Tablets Sales by Region (2016-2021e) & (M Unit)
Table 93. Global Oxcarbazepine Tablets Sales by Region (2021-2026) & (M Unit)
Table 94. Global Oxcarbazepine Tablets Revenue by Region (2016-2021e) & (USD Million)
Table 95. Global Oxcarbazepine Tablets Revenue by Region (2021-2026) & (USD Million)
Table 96. Global Oxcarbazepine Tablets Sales by Type (2016-2021e) & (M Unit)
Table 97. Global Oxcarbazepine Tablets Sales by Type (2021-2026) & (M Unit)
Table 98. Global Oxcarbazepine Tablets Revenue by Type (2016-2021e) & (USD Million)
Table 99. Global Oxcarbazepine Tablets Revenue by Type (2021-2026) & (USD Million)
Table 100. Global Oxcarbazepine Tablets Price by Type (2016-2021e) & (USD/Unit)
Table 101. Global Oxcarbazepine Tablets Price by Type (2021-2026) & (USD/Unit)
Table 102. Global Oxcarbazepine Tablets Sales by Application (2016-2021e) & (M Unit)
Table 103. Global Oxcarbazepine Tablets Sales by Application (2021-2026) & (M Unit)
Table 104. Global Oxcarbazepine Tablets Revenue by Application (2016-2021e) & (USD Million)
Table 105. Global Oxcarbazepine Tablets Revenue by Application (2021-2026) & (USD Million)
Table 106. Global Oxcarbazepine Tablets Price by Application (2016-2021e) & (USD/Unit)
Table 107. Global Oxcarbazepine Tablets Price by Application (2021-2026) & (USD/Unit)
Table 108. North America Oxcarbazepine Tablets Sales by Country (2016-2021e) & (M Unit)
Table 109. North America Oxcarbazepine Tablets Sales by Country (2021-2026) & (M Unit)
Table 110. North America Oxcarbazepine Tablets Revenue by Country (2016-2021e) & (USD Million)
Table 111. North America Oxcarbazepine Tablets Revenue by Country (2021-2026) & (USD Million)
Table 112. North America Oxcarbazepine Tablets Sales by Type (2016-2021e) & (M Unit)
Table 113. North America Oxcarbazepine Tablets Sales by Type (2021-2026) & (M Unit)
Table 114. North America Oxcarbazepine Tablets Sales by Application (2016-2021e) & (M Unit)
Table 115. North America Oxcarbazepine Tablets Sales by Application (2021-2026) & (M Unit)
Table 116. Europe Oxcarbazepine Tablets Sales by Country (2016-2021e) & (M Unit)
Table 117. Europe Oxcarbazepine Tablets Sales by Country (2021-2026) & (M Unit)
Table 118. Europe Oxcarbazepine Tablets Revenue by Country (2016-2021e) & (USD Million)
Table 119. Europe Oxcarbazepine Tablets Revenue by Country (2021-2026) & (USD Million)
Table 120. Europe Oxcarbazepine Tablets Sales by Type (2016-2021e) & (M Unit)
Table 121. Europe Oxcarbazepine Tablets Sales by Type (2021-2026) & (M Unit)
Table 122. Europe Oxcarbazepine Tablets Sales by Application (2016-2021e) & (M Unit)
Table 123. Europe Oxcarbazepine Tablets Sales by Application (2021-2026) & (M Unit)
Table 124. Asia-Pacific Oxcarbazepine Tablets Sales by Region (2016-2021e) & (M Unit)
Table 125. Asia-Pacific Oxcarbazepine Tablets Sales by Region (2021-2026) & (M Unit)
Table 126. Asia-Pacific Oxcarbazepine Tablets Revenue by Region (2016-2021e) & (USD Million)
Table 127. Asia-Pacific Oxcarbazepine Tablets Revenue by Region (2021-2026) & (USD Million)
Table 128. Asia-Pacific Oxcarbazepine Tablets Sales by Type (2016-2021e) & (M Unit)
Table 129. Asia-Pacific Oxcarbazepine Tablets Sales by Type (2021-2026) & (M Unit)
Table 130. Asia-Pacific Oxcarbazepine Tablets Sales by Application (2016-2021e) & (M Unit)
Table 131. Asia-Pacific Oxcarbazepine Tablets Sales by Application (2021-2026) & (M Unit)
Table 132. South America Oxcarbazepine Tablets Sales by Country (2016-2021e) & (M Unit)
Table 133. South America Oxcarbazepine Tablets Sales by Country (2021-2026) & (M Unit)
Table 134. South America Oxcarbazepine Tablets Revenue by Country (2016-2021e) & (USD Million)
Table 135. South America Oxcarbazepine Tablets Revenue by Country (2021-2026) & (USD Million)
Table 136. South America Oxcarbazepine Tablets Sales by Type (2016-2021e) & (M Unit)
Table 137. South America Oxcarbazepine Tablets Sales by Type (2021-2026) & (M Unit)
Table 138. South America Oxcarbazepine Tablets Sales by Application (2016-2021e) & (M Unit)
Table 139. South America Oxcarbazepine Tablets Sales by Application (2021-2026) & (M Unit)
Table 140. Middle East & Africa Oxcarbazepine Tablets Sales by Country (2016-2021e) & (M Unit)
Table 141. Middle East & Africa Oxcarbazepine Tablets Sales by Country (2021-2026) & (M Unit)
Table 142. Middle East & Africa Oxcarbazepine Tablets Revenue by Country (2016-2021e) & (USD Million)
Table 143. Middle East & Africa Oxcarbazepine Tablets Revenue by Country (2021-2026) & (USD Million)
Table 144. Middle East & Africa Oxcarbazepine Tablets Sales by Type (2016-2021e) & (M Unit)
Table 145. Middle East & Africa Oxcarbazepine Tablets Sales by Type (2021-2026) & (M Unit)
Table 146. Middle East & Africa Oxcarbazepine Tablets Sales by Application (2016-2021e) & (M Unit)
Table 147. Middle East & Africa Oxcarbazepine Tablets Sales by Application (2021-2026) & (M Unit)
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Oxcarbazepine Tablets Typical Distributors
Table 151. Oxcarbazepine Tablets Typical Customers
List of Figures
Figure 1. Oxcarbazepine Tablets Picture
Figure 2. Global Oxcarbazepine Tablets Sales Market Share by Type in 2020
Figure 3. Tablets (150mg)
Figure 4. Tablets (300mg)
Figure 5. Tablets (600mg)
Figure 6. Global Oxcarbazepine Tablets Sales Market Share by Application in 2020
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Online Pharmacy
Figure 10. Global Oxcarbazepine Tablets Market Size, (USD Million) & (M Unit): 2020 VS 2021 VS 2026
Figure 11. Global Oxcarbazepine Tablets Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Oxcarbazepine Tablets Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Oxcarbazepine Tablets Sales (2016-2026) & (M Unit)
Figure 32. Global Oxcarbazepine Tablets Production Capacity (2016-2026) & (M Unit)
Figure 33. Global Oxcarbazepine Tablets Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Oxcarbazepine Tablets Market Drivers
Figure 35. Oxcarbazepine Tablets Market Restraints
Figure 36. Oxcarbazepine Tablets Market Trends
Figure 37. Global Oxcarbazepine Tablets Sales Market Share by Manufacturer in 2020
Figure 38. Global Oxcarbazepine Tablets Revenue Market Share by Manufacturer in 2020
Figure 39. Oxcarbazepine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Oxcarbazepine Tablets Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Oxcarbazepine Tablets Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Oxcarbazepine Tablets Sales Market Share by Region (2016-2026)
Figure 43. Global Oxcarbazepine Tablets Revenue Market Share by Region (2016-2026)
Figure 44. North America Oxcarbazepine Tablets Revenue (2016-2026) & (USD Million)
Figure 45. Europe Oxcarbazepine Tablets Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Oxcarbazepine Tablets Revenue (2016-2026) & (USD Million)
Figure 47. South America Oxcarbazepine Tablets Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Oxcarbazepine Tablets Revenue (2016-2026) & (USD Million)
Figure 49. Global Oxcarbazepine Tablets Sales Market Share by Type (2016-2026)
Figure 50. Global Oxcarbazepine Tablets Revenue Market Share by Type (2016-2026)
Figure 51. Global Oxcarbazepine Tablets Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Oxcarbazepine Tablets Sales Market Share by Application (2016-2026)
Figure 53. Global Oxcarbazepine Tablets Revenue Market Share by Application (2016-2026)
Figure 54. Global Oxcarbazepine Tablets Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Oxcarbazepine Tablets Sales Market Share by Country (2016-2026)
Figure 56. North America Oxcarbazepine Tablets Revenue Market Share by Country (2016-2026)
Figure 57. North America Oxcarbazepine Tablets Sales Market Share by Type (2016-2026)
Figure 58. North America Oxcarbazepine Tablets Sales Market Share by Application (2016-2026)
Figure 59. Europe Oxcarbazepine Tablets Sales Market Share by Country (2016-2026)
Figure 60. Europe Oxcarbazepine Tablets Revenue Market Share by Country (2016-2026)
Figure 61. Europe Oxcarbazepine Tablets Sales Market Share by Type (2016-2026)
Figure 62. Europe Oxcarbazepine Tablets Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Oxcarbazepine Tablets Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Oxcarbazepine Tablets Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Oxcarbazepine Tablets Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Oxcarbazepine Tablets Sales Market Share by Application (2016-2026)
Figure 67. South America Oxcarbazepine Tablets Sales Market Share by Country (2016-2026)
Figure 68. South America Oxcarbazepine Tablets Revenue Market Share by Country (2016-2026)
Figure 69. South America Oxcarbazepine Tablets Sales Market Share by Type (2016-2026)
Figure 70. South America Oxcarbazepine Tablets Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Oxcarbazepine Tablets Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Oxcarbazepine Tablets Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Oxcarbazepine Tablets Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Oxcarbazepine Tablets Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source